CLINICAL_TRIALS
withdrawal
· 2012-01-26
Clinical Trial Update: Role of Enhanced External Counterpulsation (EECP) Therapy in Patients With Resistant Hypertension [NA]
Summary
This clinical trial update reports that a study evaluating enhanced external counterpulsation (EECP) therapy for resistant hypertension has been withdrawn. Spon…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Albert Einstein Healthcare Network | Conditions: Hypertension | NA | Status: WITHDRAWN